aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer

Reporter: J Taylor Whaley, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de junio del 2013

null

Blogs

Survivorship: A Roadmap for Managing Fear [Webinar]
by OncoLink Editorial Team
March 04, 2014

Is Ayurveda the Answer to Women’s Health Issues?
by The 4Wholeness Team
September 01, 2015